71th-Cardio-Website_EN-Mob

Satellite Sessions

June 3 | 12:30-14:00

Bayer + AstraZeneca | June 3 | 12:30-14:00

Title: Heart and Kidney in Harmony: The Game-Changing Potential of SGLT21 & ns-MRA

 

 

 

Session Agenda: TBD

Medison Pharma | June 3 | 12:30-14:00

Title: How to choose pcsk9 in the world of options

 

 

 

Session Agenda: TBD

Pfizer Pharmaceuticals Israel | June 3 | 12:30-14:00

Title: Can We Do BeTTR? Optimizing diagnosis of Cardiac Amyloidosis in Herat Failure Patients

 

Session is open for medical technicians

 

Session Agenda: TBD

Abbott Laboratories | June 3 | 12:30-14:00

Title: When Experience matters most – Mitral & TriCuspid interventions

 

 

 

Session Agenda: TBD

Novo Nordisk | June 3 | 12:30-14:00

Title: Managing Residual Risk In T2D: Innovative Strategies For Improved Outcomes

 

 

 

 Session Agenda: TBD

June 4 | 12:30-14:00

Novo Nordisk | June 4 | 12:30-14:00

Title: Reducing MACE in people with overweight or obesity and CVD 

 

 

 Session Agenda: TBD

Boehringer Ingelheim Israel | June 4 | 12:30-14:00

Title: How to Optimize the Management of Patients with Heart Failure

 

 

 

Session Agenda: TBD

Pfizer | June 4 | 12:30-14:00

Title: Navigating Cardiac Amyloidosis: Echocardiography and Differential Diagnosis in Focus

 

 

Session Agenda: TBD

Novartis Israel | June 4 | 12:30-14:00

Title: Heart Frontiers: Today’s Lipid Innovations, Tomorrow’s Standards

 

 

Session Agenda: TBD

Edwards Lifesciences | June 4 | 12:30-14:00

Title: Latest technology updates and key considerations regarding valve therapy

 

 

Session Agenda: TBD